In addition, the PI3K pathway is stimulated as a physiological ... These include mammalian target of rapamycin (mTOR) inhibitors of the 'rapalog' family of rapamycin analogues, ether lipids ...
Itovebi, approved for some patients with breast cancer, is the first PI3K inhibitor to display a survival benefit, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results